Oracle shares weekly forecast: Rebound odds stay low after nearly 5% slide on balance sheet strain
Shares of Oracle Corporation (ORCL) are trading near $119 after dropping close to 5% this week, as rebound odds remain low. Corporate activity and balance sheet strain linger over the stock, setting the tone for a cautious outlook heading into the new week.
Highlights
- Shares of Oracle have dropped 4.9% in the past week to $119.25, trading below all key daily moving averages.
- Technical signals remain negative with downside momentum and consolidation expected below resistance at $126.06.
- The projected trading range for the week ahead is $112.46 to $126.03, with support at $115.59 and strong downside risk.
Leverage jumps as aggressive debt and equity sale fuels AI expansion
Oracle completed a $10 billion senior notes offering alongside a $10 billion common stock sale at $116 per share to fuel its AI data center expansion, according to Yahoo Finance. This aggressive funding move has resulted in higher leverage and negative free cash flow, contributing to recent underperformance. Oracle also announced new federal contracts by adding the Department of Veterans Affairs and Department of War to its Health Information Network.
Bearish momentum persists as downside risk dominates despite neutral oscillators
The daily chart reveals a decisive downside move with volatility at 13.12%, but without a sustained trend, reflecting a sharp move lower without a sustained trend. Momentum signals remain negative, as seen in the MACD reading of -4.57 (Strong Sell), while oscillator readings from the RSI and CCI are neutral. Immediate support stands at $115.59, with resistance at $126.06 from the MA-20 and additional resistance from the Ichimoku Kijun at $128.87. Overall, indicators point to further risk on the downside, while range-bound action persists.
Downside bias prevails in the coming week amid resistance at $126.06
In the week ahead, Oracle is expected to trade between $112.46 and $126.03, with a very high probability of a decrease (more than 80%) and a very low probability of an increase (less than 20%). The base case sees continued consolidation below resistance at $126.06. Upside attempts above $126.06 would challenge $128.87, but the risk remains tilted downward. A break below support at $115.59 would open the door for further declines toward the lower end of the expected range.
Earlier, analysts noted that Oracle shares remained under pressure despite ongoing federal health network expansion and AI-focused initiatives, with technicals favoring a cautious near-term stance. The latest developments reinforce expectations for continued weakness, with traders advised to monitor the $115.59 support level for signs of further downside risk.